Answers are grounded in this paper and cite their sources.
Prospective analysis shows improved detection rates of marked nodes in patients with node-positive breast cancer, suggesting enhanced treatment outcomes.
This large prospective analysis of patients with initially clinically node-positive BC receiving NACT demonstrates that probe-guided detection markers used to mark metastatic nodes before NACT provide superior detection rates.
No takes yet. Share an insight, caveat, or question.
Banys-Paluchowski et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: